Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001615219-16-000130)

Filing Details

Accession Number:: 0001615219-16-000130
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-16 11:16:38
Reporting Period:: 2016-03-15

Filing Date:: 2016-03-16
Accepted Time:: 2016-03-16 11:16:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1615219	Flex Pharma Inc.	FLKS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1448355	Michelle Stacy	C/O Flex Pharma, Inc. 800 Boylston Street, 24Th Floor Boston MA 02199		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-15	2,585	$9.63	2,585	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $9.54 to $9.70. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.